Heron Therapeutics Inc

+0.04 (+3.60%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)137.67M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$31.7 Million
Adjusted EPS-$0.22
See more estimates
10-Day MA$1.20
50-Day MA$1.95
200-Day MA$2.89
See more pivots

Heron Therapeutics Inc Stock, NASDAQ:HRTX

4242 Campus Point Court, Suite 200, San Diego, California 92121
United States of America
Phone: +1.858.251.4400
Number of Employees: 203


Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.